Healthcare
Madrigal Pharmaceuticals, Inc.
MDGL$533.12-2.48%
Price is delayed.
Add to watchlist
About Madrigal Pharmaceuticals, Inc.
Madrigal Pharmaceuticals makes drugs to treat MASH, a liver disease where fat builds up in the liver and causes damage. The company's main product is Rezdiffra, which is a pill that targets how the liver processes thyroid hormone to reduce this fat buildup. The company was founded in 2016 and is based in Pennsylvania.
Loading chart...
Members only
Full research is for ConvictionStocks members
Members read the rest of this page. Where we have it for this company, that is:
- What each number means, in plain English, with the Wall Street name where the two differ.
- A plain-English summary of the company.
- How many analysts cover it, and the count behind each rating.
- Recent news, dated.
Get the free weekly market digest
The week's biggest movers, every Sunday. No spam.
Look up another company
Related Research
More Healthcare stocks to explore